Geospatial disparities in federal COVID-19 test-to-treat program
View ORCID ProfileEmily R. Smith, Erin M. Oakley
doi: https://doi.org/10.1101/2022.08.02.22278349
Emily R. Smith
1Department of Global Health, Milken Institute School of Public Health, George Washington University
ScD, MPHErin M. Oakley
1Department of Global Health, Milken Institute School of Public Health, George Washington University
MPHArticle usage
Posted August 03, 2022.
Geospatial disparities in federal COVID-19 test-to-treat program
Emily R. Smith, Erin M. Oakley
medRxiv 2022.08.02.22278349; doi: https://doi.org/10.1101/2022.08.02.22278349
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)